Nuzenio

Diagnostics Submits Fda

Diagnostics Submits Fda news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Co-Diagnostics Submits FDA Notification for Upper Respiratory Multiplex Test - Clinical Lab ProductsClinical Lab Products · Thu, 06 Aug 2026 14:43:11 GMTFDA Clears Proscia Digital Pathology Platform for New Scanner Compatibility - Clinical Lab ProductsClinical Lab Products · Thu, 06 Aug 2026 14:43:11 GMTRoche Expands Cyclospora Research Testing Portfolio Amid US Outbreak - Clinical Lab ProductsClinical Lab Products · Thu, 06 Aug 2026 14:28:25 GMTCo-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test - PR NewswirePR Newswire · Thu, 06 Aug 2026 13:30:00 GMTCo-Diagnostics' Test Filing Draws on 1,400 Patients - Stock TitanStock Titan · Thu, 06 Aug 2026 13:30:00 GMTNatera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - biospace.combiospace.com · Thu, 06 Aug 2026 03:07:25 GMTAfter U.S. approval, Natera submits bladder cancer test in Japan - Stock TitanStock Titan · Wed, 05 Aug 2026 10:00:00 GMT

Timeline

Thu, 06 Aug 2026 14:43:11 GMTCo-Diagnostics Submits FDA Notification for Upper Respiratory Multiplex Test - Clinical Lab Products
Thu, 06 Aug 2026 14:43:11 GMTFDA Clears Proscia Digital Pathology Platform for New Scanner Compatibility - Clinical Lab Products
Thu, 06 Aug 2026 14:28:25 GMTRoche Expands Cyclospora Research Testing Portfolio Amid US Outbreak - Clinical Lab Products
Thu, 06 Aug 2026 13:30:00 GMTCo-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test - PR Newswire
Thu, 06 Aug 2026 13:30:00 GMTCo-Diagnostics' Test Filing Draws on 1,400 Patients - Stock Titan
Thu, 06 Aug 2026 03:07:25 GMTNatera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - biospace.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Diagnostics Submits Fda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.